|
|
 Breast Cancer Information - December 3, 2008
| Scientists may have pinpointed a telltale set of genes which appear to predict if breast cancer will spread to the lungs. A team from the Memorial Sloan-Kettering Cancer Center says the genetic "signature" may help predict how serious the disease may be | | Green tea probably does not help prevent breast, prostate or any other type of cancer, the U.S. Food and Drug Administration said on Thursday. THE F.D.A. went on to say that studies supporting the assertions about the medical power of green tea are weak | |
Christina Ficara - All Headline News Staff Reporter The problems developed in women given the standard intravenous drug doxorubicin along with a newer drug called docetaxel. The two drugs are frequently used alone to treat breast cancer. Scientists have been exploring the effects of combining them, with mixed results | | GlaxoSmithKline Plc's experimental cancer pill, Lapatinib, is effective as a first-line breast cancer treatment, but regulatory approval will not be sought before late 2006 or early 2007 after more data is collected. London-based Glaxo said interim results from a mid-stage trial of the drug in 40 women with advanced breast cancer showed that 35 percent had their tumors shrink by at least 30 percent | | Researchers discovered that patients with advanced lung cancer or advanced breast cancer who took Genentech Inc.'s cancer drug Avastin in combination with chemotherapy took longer to relapse than patients who took chemotherapy alone. The data from two late-stage trials was released at the annual meeting of the American Society of Clinical Oncology in Orlando, Florida | |
|
|